SITARAK-M is an advanced combination therapy specially formulated for the effective management of Type 2 Diabetes Mellitus. Combining the power of Sitagliptin Phosphate 50 mg and Metformin Hydrochloride 500 mg, this medication provides a dual-action approach to support better blood sugar control and metabolic balance.
Sitagliptin Phosphate helps improve insulin release and reduce excess blood sugar levels by supporting the body’s natural incretin system. Metformin Hydrochloride helps decrease glucose production in the liver while improving insulin sensitivity for enhanced glycemic control.
Together, this trusted combination helps maintain healthy blood sugar levels, supports metabolic health, and contributes to long-term diabetes management. Manufactured under strict pharmaceutical quality standards, SITARAK-M ensures safe, effective, and reliable diabetic care.
Key Benefits
✔ Helps control blood sugar effectively
✔ Dual-action anti-diabetic formula
✔ Improves insulin sensitivity
✔ Helps reduce hepatic glucose production
✔ Supports better glycemic control
✔ Promotes long-term metabolic benefits
✔ Safe & effective formulation
✔ Trusted combination for diabetes management
Reviews
There are no reviews yet.